Skip to main content
. 2023 Feb 6;250:115186. doi: 10.1016/j.ejmech.2023.115186

Fig. 2.

Fig. 2

Left. Overview of the screening. SARS-CoV-2 3CLpro inhibition was reported (%) for each incubate. Green dots: tested compounds at 30 μM, Red dots: positive controls (incubations with vehicle), Blue dots: negative controls (incubations w/o enzyme), Orange dots: reference compound Boceprevir at 40 μM, Light orange dots: Boceprevir at 4 μM. Right. Workflow of the screening campaign.